The meta-analysis results showed that serum ASP levels in NAFLD patients were higher than those in the control group (MD: 5.17, 95% CI [2.57~7.77]) (I2 = 97%, P for heterogeneity<0.00001). Here, C3 is linked to metabolic dysfunction-associated steatotic liver disease.